2m 2m 2m 2m 2m 2m 2m
ERNEXA THERAPE (ERNA)
NASDAQ
$4.32+$0.15 (+3.60%)
Price as of Sep 11, 2026 7:57 PM EDT- $4.9MMarket Cap
- -87.09%1-Year Change
- BiotechnologyIndustry
ERNEXA THERAPE (ERNA)
$4.32+$0.15 (+3.60%)
ERNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.17 | ||
Change | +$0.15 (+3.61%) | ||
Open | $4.05 | ||
High | $4.42 | ||
Low | $4.03 | ||
Previous Close | $4.02 | ||
Volume | 19,816 | ||
30-Day Average Volume | 29,891 | ||
1-Week Change | -3.36% | ||
1-Month Change | -5.13% | ||
1-Year Change | -87.09% | ||
3-Year Change | -99.49% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.2M | ||
Total Assets | $6.3M | ||
Market Cap | $4.9M | ||
Enterprise Value | $629,776.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.0M | ||
Free Cash Flow | -$4.2M | ||
EBIT | -$4.0M | ||
EBITDA | -$4.0M | ||
Net Working Capital | $3.0M | ||
EPS | -$3.40 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 05/04/2026 | ||
Earnings & Revenue